Speech-Language Pathologists in Farmington, AR Accepting Medicare

25 Speech-Language Pathologists found. Showing 21 - 25

Mrs. Pamela K Petray, MA CCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 91 Neal St, Hope For Tomorrow, Farmington, AR 72730 Phone: 479-267-4673

Alexia Allen Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Southwinds Rd Ste 2, Farmington, AR 72730 Phone: 870-932-3600

Mrs. Kimber Michelle Still, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 Signature Dr, Farmington, AR 72730 Phone: 903-293-0927

Mrs. Nancy Marie Whitten Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 91 Neal, Hope For Tomorrow, Farmington, AR 72730 Phone: 479-267-4673    Fax: 479-267-4880

Ms. Sarah Dianne Post, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 N Double Springs Rd, Farmington, AR 72730 Phone: 479-267-5960    Fax: 479-267-5965

News Archive

RI Defeats Hepatitis C project aims to eliminate HCV in Rhode Island

Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection program, states in the July, 2014 Rhode Island Medical Journal special edition, "RI Defeats Hep C" that eliminating hepatitis c virus infection (hep c or HCV) is feasible, can provide economic benefits, enhance capacity to address other health challenges, and improve health care disparities.

Amneal Pharmaceuticals to acquire assets of Interpharm Holdings

Amneal Pharmaceuticals, LLC has announced the execution of an Asset Purchase Agreement for Amneal's wholly-owned subsidiary, Amneal Pharmaceuticals of New York, LLC, to acquire the assets, facilities and business of Interpharm. The acquisition includes Interpharm's facilities on Long Island, New York as well as the intellectual property including ANDA's, technology and processes.

University of Iowa, Mayo Clinic to continue SPORE for lymphoma research

The Mayo Clinic Cancer Center and Holden Comprehensive Cancer Center at the University of Iowa have received a five-year, $11.5 million grant renewal from the National Cancer Institute (NCI) to continue the Specialized Program of Research Excellence (SPORE) for lymphoma research.

Latest findings put Benson Viscometers at the forefront of Covid-19 fight

A clinical viscosity diagnostic instrument is proving to be valuable in the research and treatment of coronavirus after laboratory scientists have identified its ability to provide meaningful data for medical teams treating Covid-19 patients.

Read more Medical News

› Verified 5 days ago

• 1
• 2(current)